Linical Company Overview
- Year Founded
-
2005

- Status
-
Public
- Employees
-
635

- Stock Symbol
-
2183

- Investments
-
3
- Share Price
-
$2.26
- (As of Tuesday Closing)
Linical Company General Information
Description
Linical Co Ltd is a pharmaceutical company.
Contact Information
Website
www.linical.comCorporate Office
- 10th Floor, Shin-Osaka Brick Building
- 6-1, Miyahara 1-chome, Yodogawa-ku
- Osaka, 532-0003
- Japan
Corporate Office
- 10th Floor, Shin-Osaka Brick Building
- 6-1, Miyahara 1-chome, Yodogawa-ku
- Osaka, 532-0003
- Japan
Linical Company Stock Performance
As of 08-Jul-2025, Linical Company’s stock price is $2.26. Its current market cap is $51.1M with 22.6M shares.
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$2.26 | $2.26 | $1.77 - $2.88 | $51.1M | 22.6M | 29.5K | -$0.16 |
Linical Company Financials Summary
As of 31-Mar-2025, Linical Company has a trailing 12-month revenue of $68.4M.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 |
---|---|---|---|---|
EV | 15,844 | 15,844 | 28,340 | 94,708 |
Revenue | 68,446 | 68,446 | 85,182 | 92,457 |
EBITDA | (159) | (159) | 7,917 | 13,958 |
Net Income | (3,535) | (3,535) | 2,341 | 7,419 |
Total Assets | 112,103 | 112,103 | 122,497 | 131,070 |
Total Debt | 15,557 | 15,557 | 19,149 | 26,584 |
Linical Company Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Linical Company Signals
Linical Company Investments & Acquisitions (3)
Linical Company’s most recent deal was a Seed Round with Gideon for . The deal was made on 31-Aug-2020.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Gideon | 31-Aug-2020 | Seed Round | Machinery (B2B) | ||
Accelovance | 17-Apr-2018 | Merger/Acquisition | Other Healthcare Services | ||
Nuvisan CDD Holding | 01-Dec-2014 | Merger/Acquisition | Biotechnology |
Linical Company ESG
Risk Overview
Risk Rating
Updated April, 24, 2024
21.63 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,216
Rank
Percentile

Pharmaceuticals
Industry
of 921
Rank
Percentile

Laboratory Equipment and Services
Subindustry
of 64
Rank
Percentile

Linical Company FAQs
-
When was Linical Company founded?
Linical Company was founded in 2005.
-
Where is Linical Company headquartered?
Linical Company is headquartered in Osaka, Japan.
-
What is the size of Linical Company?
Linical Company has 635 total employees.
-
What industry is Linical Company in?
Linical Company’s primary industry is Drug Discovery.
-
Is Linical Company a private or public company?
Linical Company is a Public company.
-
What is Linical Company’s stock symbol?
The ticker symbol for Linical Company is 2183.
-
What is the current stock price of Linical Company?
As of 08-Jul-2025 the stock price of Linical Company is $2.26.
-
What is the current market cap of Linical Company?
The current market capitalization of Linical Company is $51.1M.
-
What is Linical Company’s current revenue?
The trailing twelve month revenue for Linical Company is $68.4M.
-
What is Linical Company’s annual earnings per share (EPS)?
Linical Company’s EPS for 12 months was -$0.16.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »